Singapore company to start clinical safety trials in humans for potential COVID-19 treatment

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 66%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

SINGAPORE: A Singapore-based company will start human clinical trials next week for a treatment that could slow down the progression of COVID-19 ...

SINGAPORE: A Singapore-based company will start human clinical trials next week for a treatment that could slow down the progression of COVID-19 in patients, help them recover faster, and provide temporary protection against the coronavirus.

Tychan may become the first firm to start its human clinical trial in Singapore, although efforts in developing an antibody-based treatment For those who already require oxygen, the hope is that the drug will prevent them from needing a ventilator, and for patients who are already on ventilators, that they could go off the ventilators, he added.

The drug will also be evaluated for its potential to provide temporary protection against infection with SARS-CoV-2, Tychan said. The potential treatment was developed in partnership with the Ministry of Defence, Ministry of Health, the Economic Development Board and other Government agencies as part of a whole-of-Government effort.

“It has also successfully completed pre-clinical safety studies and other regulatory requirements, including a three-week drug stability test. These were all completed in less than four months before this first-in-human infusion,” Tychan said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in CA

Canada Canada Latest News, Canada Canada Headlines